Search for: "Pfizer Pharmaceutic, Inc."
Results 501 - 520
of 667
Sorted by Relevance
|
Sort by Date
16 Jul 2015, 4:00 am
Pfizer Ireland Pharmaceuticals 2006 FC 1465, where Lilly sought to impeach Pfizer’s patent on the Cialis drug and sought to get access to communications between the inventors and the U.K. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
10 Jun 2009, 10:00 pm
Pfizer, Inc., 584 F. [read post]
2 Jun 2010, 8:50 am
Department of Energy 82 Teach for America 83 Abbott 84 AT&T 85 MGM Mirage 86 Mayo Clinic 87 Lockheed Martin Corporation 88 Merck 89 Limited Brands 90 Hyatt Hotels and Resorts 91 Colgate-Palmolive Company 92 Dell Inc. 93 Lilly 94 Novartis Pharmaceuticals Corporation 95 The Vanguard Group 96 Oracle 97 Vestas 98 Wal-Mart Stores Inc. 99 Honda Companies 100 [read post]
23 Aug 2021, 2:12 am
In the case of Xalatan®, In January 2004, the Essential Inventions, Inc. [read post]
18 Jan 2016, 5:00 am
Pfizer, Inc., ___ F. [read post]
29 Dec 2008, 9:00 pm
Pfizer Inc., 867 N.Y.S.2d 425 (N.Y.A.D. 2008) (state appellate holding that plaintiff's home state controls on choice of law; similar to, but much better than, Desiano); (15) Vanderwerf v. [read post]
8 Jan 2009, 4:07 am
Pfizer, Inc., 253 F.R.D. 11, 16-17 (D. [read post]
5 Apr 2012, 11:54 am
Pfizer, Inc., ___ F. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
6 Feb 2009, 8:19 am
(in support of petitioner) Brief amicus curiae of Ivax Pharmaceuticals, Inc. [read post]
24 Jan 2012, 6:34 pm
” See Caraco, 527 F.3d at 1293; see also Pfizer, 726 F. [read post]
29 May 2015, 8:25 am
The NLDC produced a development plan that would revitalize Fort Trumbull by building housing, office space, and other facilities that would support a new headquarters that Pfizer, Inc. [read post]
10 Feb 2011, 5:35 pm
The ‘217 patent is one of four patents listed in the Orange Book for Pfizer, Inc. [read post]
15 Sep 2009, 10:54 pm
The Takeda case [Takeda Pharmaceutical Co. v. [read post]
1 Mar 2007, 5:50 am
Pfizer, Inc., 381 F. [read post]
19 Mar 2012, 3:57 am
IMS Health, Inc., 131 S. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
17 Sep 2020, 4:55 am
Although that sentence never identified Pfizer as a pharmaceutical company, Parallel Search understood to deliver cases related to the pharma industry, and it also knew to deliver cases related to an FLSA exemption for outside sales people. [read post]
